Business Description
Vilin Bio Med Ltd
ISIN : INE0L4V01013
Compare
Compare
Traded in other countries / regions
VILINBIO.India IPO Date
2023-06-30Description
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.18 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 3.69 | |||||
Interest Coverage | 3.48 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.62 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.93 | |||||
9-Day RSI | 56.95 | |||||
14-Day RSI | 54.36 | |||||
6-1 Month Momentum % | -31.91 | |||||
12-1 Month Momentum % | -34.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.71 | |||||
Quick Ratio | 3.37 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 184.19 | |||||
Days Sales Outstanding | 538.13 | |||||
Days Payable | 61.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -44.26 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.82 | |||||
Operating Margin % | 17.17 | |||||
Net Margin % | 10.06 | |||||
FCF Margin % | -79.72 | |||||
ROE % | 3.28 | |||||
ROA % | 2.49 | |||||
ROIC % | 4.1 | |||||
ROC (Joel Greenblatt) % | 7.74 | |||||
ROCE % | 5.98 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.2 | |||||
PE Ratio without NRI | 36.2 | |||||
PS Ratio | 3.65 | |||||
PB Ratio | 1.18 | |||||
Price-to-Tangible-Book | 1.18 | |||||
EV-to-EBIT | 18.78 | |||||
EV-to-EBITDA | 17.82 | |||||
EV-to-Revenue | 3.49 | |||||
EV-to-FCF | -4.37 | |||||
Price-to-Graham-Number | 1.05 | |||||
Price-to-Net-Current-Asset-Value | 1.45 | |||||
Earnings Yield (Greenblatt) % | 5.33 | |||||
FCF Yield % | -22.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vilin Bio Med Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 76.457 | ||
EPS (TTM) (₹) | 0.55 | ||
Beta | 0 | ||
Volatility % | 39.38 | ||
14-Day RSI | 54.36 | ||
14-Day ATR (₹) | 0.780368 | ||
20-Day SMA (₹) | 19.2875 | ||
12-1 Month Momentum % | -34.69 | ||
52-Week Range (₹) | 15.75 - 30.45 | ||
Shares Outstanding (Mil) | 13.95 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vilin Bio Med Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vilin Bio Med Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Vilin Bio Med Ltd Frequently Asked Questions
What is Vilin Bio Med Ltd(NSE:VILINBIO)'s stock price today?
The current price of NSE:VILINBIO is ₹19.85. The 52 week high of NSE:VILINBIO is ₹30.45 and 52 week low is ₹15.75.
When is next earnings date of Vilin Bio Med Ltd(NSE:VILINBIO)?
The next earnings date of Vilin Bio Med Ltd(NSE:VILINBIO) is .
Does Vilin Bio Med Ltd(NSE:VILINBIO) pay dividends? If so, how much?
Vilin Bio Med Ltd(NSE:VILINBIO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |